These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Visceral and subcutaneous adiposity: are both potential therapeutic targets for tackling the metabolic syndrome? Rodríguez A; Catalán V; Gómez-Ambrosi J; Frühbeck G Curr Pharm Des; 2007; 13(21):2169-75. PubMed ID: 17627548 [TBL] [Abstract][Full Text] [Related]
5. [High fat diet and lipotoxicity]. Inoue G; Koh M; Nakao K Nihon Rinsho; 2002 Jul; 60 Suppl 7():626-31. PubMed ID: 12238109 [No Abstract] [Full Text] [Related]
6. Glucose intolerance and resistin expression in rat offspring exposed to ethanol in utero: modulation by postnatal high-fat diet. Chen L; Nyomba BL Endocrinology; 2003 Feb; 144(2):500-8. PubMed ID: 12538610 [TBL] [Abstract][Full Text] [Related]
7. Targeting the liver in the metabolic syndrome: evidence from animal models. Petruzzelli M; Lo Sasso G; Portincasa P; Palasciano G; Moschetta A Curr Pharm Des; 2007; 13(21):2199-207. PubMed ID: 17627553 [TBL] [Abstract][Full Text] [Related]
8. [High risk pathophysiology and the molecular mechanism of arteriosclerosis]. Yamada N Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1667-75. PubMed ID: 17037299 [No Abstract] [Full Text] [Related]
13. Type 2 diabetes and cardiovascular disease: getting to the fat of the matter. Goralski KB; Sinal CJ Can J Physiol Pharmacol; 2007 Jan; 85(1):113-32. PubMed ID: 17487251 [TBL] [Abstract][Full Text] [Related]
14. Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-alpha agonist treatment is accompanied by paradoxical increase of circulating resistin levels. Haluzik MM; Lacinova Z; Dolinkova M; Haluzikova D; Housa D; Horinek A; Vernerova Z; Kumstyrova T; Haluzik M Endocrinology; 2006 Sep; 147(9):4517-24. PubMed ID: 16740970 [TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulation of the GLUT4 gene: from PPAR-gamma and FOXO1 to FFA and inflammation. Armoni M; Harel C; Karnieli E Trends Endocrinol Metab; 2007 Apr; 18(3):100-7. PubMed ID: 17317207 [TBL] [Abstract][Full Text] [Related]
16. The significance of anthocyanins in the prevention and treatment of type 2 diabetes. Różańska D; Regulska-Ilow B Adv Clin Exp Med; 2018 Jan; 27(1):135-142. PubMed ID: 29521054 [TBL] [Abstract][Full Text] [Related]
17. Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis? Cengiz C; Ardicoglu Y; Bulut S; Boyacioglu S Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):813-9. PubMed ID: 19820404 [TBL] [Abstract][Full Text] [Related]
18. Adipokines and the insulin resistance syndrome in familial partial lipodystrophy caused by a mutation in lamin A/C. Wong SP; Huda M; English P; Bargiota A; Wilding JP; Johnson A; Corrall R; Pinkney JH Diabetologia; 2005 Dec; 48(12):2641-9. PubMed ID: 16320084 [TBL] [Abstract][Full Text] [Related]
19. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. Graham TE; Yang Q; Blüher M; Hammarstedt A; Ciaraldi TP; Henry RR; Wason CJ; Oberbach A; Jansson PA; Smith U; Kahn BB N Engl J Med; 2006 Jun; 354(24):2552-63. PubMed ID: 16775236 [TBL] [Abstract][Full Text] [Related]
20. Adipose tissue as an endocrine organ. Galic S; Oakhill JS; Steinberg GR Mol Cell Endocrinol; 2010 Mar; 316(2):129-39. PubMed ID: 19723556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]